Literature DB >> 5112213

Mental retardation in patients with Duchenne progressive muscular dystrophy.

A Kozicka, J Prot, R Wasilewski.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5112213     DOI： 10.1016/0022-510x(71)90090-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  8 in total

1.  Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy.

Authors:  G G Marsh; T L Munsat
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

Review 2.  Hypotheses and recent findings concerning aetiology and pathogenesis of the muscular dystrophies.

Authors:  F Jerusalem
Journal:  J Neurol       Date:  1976       Impact factor: 4.849

3.  Intelligence level of patients with the Duchenne type of progressive muscular dystrophy (pmd-d).

Authors:  M Florek; S Karolak
Journal:  Eur J Pediatr       Date:  1977-11-04       Impact factor: 3.183

4.  Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  J Int Neuropsychol Soc       Date:  2001-01       Impact factor: 2.892

5.  Intellectual function in muscular dystrophies.

Authors:  T Glaub; F Mechler
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 6.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

7.  Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Clin Proteomics       Date:  2015-11-23       Impact factor: 3.988

8.  Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

Authors:  M S Alexander; M J Gasperini; P T Tsai; D E Gibbs; J M Spinazzola; J L Marshall; M J Feyder; M T Pletcher; E L P Chekler; C A Morris; M Sahin; J F Harms; C J Schmidt; R J Kleiman; L M Kunkel
Journal:  Transl Psychiatry       Date:  2016-09-27       Impact factor: 6.222
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.